Growth Metrics

Protalix BioTherapeutics (PLX) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -13.32%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 17.12%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -10.19%
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 24.11%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 12.18%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 3.92%
10 Protalix BioTherapeutics 164.49 Mn 153.70 Mn 29.62 Mn 9.06%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 9.06%
Dec 31, 2025 6.27%
Sep 30, 2025 1.64%
Jun 30, 2025 2.97%
Mar 31, 2025 -1.17%
Dec 31, 2024 -7.68%
Sep 30, 2024 -0.77%
Jun 30, 2024 -0.60%
Mar 31, 2024 1.64%
Dec 31, 2023 9.22%
Sep 30, 2023 0.15%
Jun 30, 2023 -2.75%
Mar 31, 2023 -3.88%
Dec 31, 2022 -8.24%
Sep 30, 2022 -7.66%
Jun 30, 2022 -4.47%
Mar 31, 2022 1.37%
Dec 31, 2021 2.41%
Sep 30, 2021 9.18%
Jun 30, 2021 4.13%
Mar 31, 2021 -3.67%
Dec 31, 2020 -8.12%
Sep 30, 2020 -16.76%
Jun 30, 2020 -19.00%
Mar 31, 2020 -17.27%
Dec 31, 2019 -17.48%
Sep 30, 2019 -15.92%
Jun 30, 2019 -14.74%
Mar 31, 2019 -17.14%
Dec 31, 2018 -16.75%
Sep 30, 2018 -17.00%
Jun 30, 2018 -14.93%
Mar 31, 2018 -13.70%
Dec 31, 2017 -11.80%
Sep 30, 2017 -12.63%
Jun 30, 2017 -13.95%
Mar 31, 2017 -9.00%
Dec 31, 2016 -10.68%
Dec 31, 2015 -13.63%
Dec 31, 2014 -17.72%
Mar 31, 2014 -16.60%
Dec 31, 2013 -15.94%
Sep 30, 2013 -13.95%
Jun 30, 2013 -13.50%
Mar 31, 2013 -10.29%
Dec 31, 2012 -10.73%
Sep 30, 2012 -9.97%
Jun 30, 2012 -8.46%
Dec 31, 2011 4.68%